title: Anti-macrophage-derived chemokine antibody relieves murine lupus nephritis.
abstract: We observed the distribution of monocyte's changes in damage to renal tissue and the expression of macrophage-derived chemokine (MDC) in MRL/lpr mice. The 8-week-old MRL/lpr mice were randomly assigned to receive either MDC antibodies (n = 6) or placebo (n = 6) at a once-every-other-day dose of 300 μl from week 4. We then quantified the differences in 24-h urine protein and serum creatinine concentrations, performed a histological evaluation of renal tissue and assessed the expression of MDC protein and mRNA between the two groups 4 weeks after treatment was initiated. Antibody-treated mice demonstrated significantly lower urine protein and serum creatinine concentrations and had fewer renal lesions compared with control mice. The expression of MDC protein and mRNA in renal tissues was significantly lower in the antibody-treated mice than in control mice, suggesting that the elevated expression of MDC, which led to monocyte infiltration in the kidney, may play an important role in the development of lupus nephritis. Furthermore, the anti-MDC antibodies may act to alleviate the renal lesions of murine lupus nephritis by inhibiting the infiltration of monocytes in the renal tissue of the lupus mice.
authors.affiliation: Department of Rheumatology and Immunology, The First Affiliated Hospital of China Medical University, 110001 Shenyang, China. liuhaina2009@hotmail.com
authors.forename: Haina
authors.initials: H
authors.lastname: Liu
authors.forename: Cheng
authors.initials: C
authors.lastname: Diao
authors.forename: Chunling
authors.initials: C
authors.lastname: Wu
authors.forename: Liping
authors.initials: L
authors.lastname: Xia
authors.forename: Hongmei
authors.initials: H
authors.lastname: Duan
authors.forename: Fang
authors.initials: F
authors.lastname: Fang
authors.forename: Shuang
authors.initials: S
authors.lastname: Ding
authors.forename: Weiguo
authors.initials: W
authors.lastname: Xiao
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D054422:Chemokine CCL22 / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D018925:Chemokines / Q000276:immunology*; D004195:Disease Models, Animal; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D007668:Kidney / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008181:Lupus Nephritis / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D051379:Mice; D019463:Mice, Inbred MRL lpr; D011507:Proteinuria / Q000628:therapy; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D054422:Chemokine CCL22; D018925:Chemokines; D012333:RNA, Messenger
references.citation: J Biol Chem. 1997 Jun 6;272(23):15036-42
references.pmid: 9169480
references.citation: J Am Soc Nephrol. 1996 Nov;7(11):2271-8
references.pmid: 8959617
references.citation: Blood. 1998 Oct 15;92(8):2668-71
references.pmid: 9763548
references.citation: J Am Soc Nephrol. 2007 Aug;18(8):2350-8
references.pmid: 17625118
references.citation: J Clin Invest. 2002 Dec;110(11):1675-86
references.pmid: 12464673
references.citation: Clin Exp Rheumatol. 1995 May-Jun;13(3):339-43
references.pmid: 7554561
references.citation: Inflamm Res. 2007 Jul;56(7):304-10
references.pmid: 17659436
references.citation: J Clin Invest. 1999 Oct;104(8):1097-105
references.pmid: 10525048
references.citation: J Exp Med. 2000 Jan 17;191(2):265-74
references.pmid: 10637271
references.citation: J Biol Chem. 1998 Jan 16;273(3):1764-8
references.pmid: 9430724
references.citation: Am J Pathol. 2003 Apr;162(4):1061-73
references.pmid: 12651599
references.citation: J Immunol. 1998 Nov 1;161(9):5027-38
references.pmid: 9794440
references.citation: Int Immunol. 1999 Jan;11(1):81-8
references.pmid: 10050676
references.citation: Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;62(6):357-63
references.pmid: 1280885